Search the Newsreel

Earnings call transcript: Mesa Laboratories posts Q1 2026 revenue miss

Victoria Creamer Sells 4,179 Shares of Charles River Laboratories International (NYSE:CRL) Stock

Victoria Creamer, EVP of Charles River Laboratories International (NYSE:CRL), sold 4,179 shares for over $1.08 million, reducing her holdings by 12.21%. Despite the insider sale, the company recently reported strong quarterly earnings, beating estimates with $3.02 EPS and $1 billion in revenue, and analysts …

Mesa Laboratories Inc /Co/ 2026: Revenue $60.14M, EPS $0.49— 10-Q Summary

Mesa Laboratories Inc /Co/ reported its 2026 quarterly results with revenue slightly up to $60.14M from $59.54M the previous year. However, net income decreased by 40.3% to $2.83M, and diluted EPS fell by 42.4% to $0.49. The company highlighted revenue growth in Calibration Solutions …

Mesa Laboratories (MLAB) lifts Q1 margins and cash flow while net income falls

Mesa Laboratories (MLAB) reported Q1 FY2027 revenue of $60,138, a 1.0% increase year-over-year, with gross profit rising to $39,012 due to improved gross margins. Operating income more than doubled to $7,031, and operating cash flow strengthened significantly to $14,736, leading to a net debt …

Michael Gunnar Knell Sells 6,645 Shares of Charles River Laboratories International (NYSE:CRL) Stock

Michael Gunnar Knell, Chief Accounting Officer at Charles River Laboratories International (NYSE:CRL), recently sold 6,645 shares of the company's stock for approximately $1.73 million, reducing his stake by 35.92%. Despite this insider selling, the company reported strong quarterly earnings, beating analyst estimates, and has …

Is Mesa Laboratories Inc (MLAB) Undervalued After Q1 Earnings Mi

IDEXX Laboratories Inc. stock outperforms competitors on strong trading day

IDEXX Laboratories Inc. (IDXX) saw its stock rally by 1.55% to $595.76 on Monday, performing strongly despite an overall poor trading session for the broader market. The S&P 500 Index and Dow Jones Industrial Average both experienced declines. IDEXX Laboratories Inc. is currently trading …

Charles River (CRL) finance chief sells 6,645 shares after exercising 2,345 options

Michael Gunnar Knell, SVP of Finance and Chief Accounting Officer at Charles River Laboratories International, Inc. (CRL), reported exercising 2,345 stock options and selling 6,645 shares of common stock on August 6, 2026. The options were exercised at strike prices between $179.66 and $208.44, …

Wheaton Precious Metals Corp. stock falls Monday, underperforms market

Wheaton Precious Metals Corp. (WPM) saw its stock fall by 0.84% to C$185.75 on Monday, underperforming the Canadian market as the S&P/TSX Composite Index rose 0.21%. The company's shares closed 18.1% below their 52-week high of C$226.68, which was reached on March 2nd. This …

Mesa Laboratories (NASDAQ:MLAB) Issues Earnings Results, Misses Expectations By $2.14 EPS

James Foster (CRL) files Form 144 for 28,733-share option sale

James Foster, an insider at Charles River Laboratories International, Inc. (CRL), has filed a Form 144 indicating his plan to sell 28,733 shares of common stock. These shares will be acquired through the exercise of stock options for cash on August 10, 2026, with …

Charles River (CRL) EVP Victoria Creamer exercises options and sells 4,179 shares

Victoria L. Creamer, EVP & Chief People Officer of Charles River Laboratories International, Inc. (CRL), exercised stock options for 4,179 shares at $179.66 per share and immediately sold them for $259.16 per share on August 6, 2026. This transaction resulted in approximately $332K pre-tax …

Dr. Reddy's Laboratories Ltd (RDY) Stock Analysis: Navigating A 10.69% Upside Potential Amidst Revenue Challenges

Dr. Reddy's Laboratories Ltd (RDY) presents a potential 10.69% upside for investors, operating as a significant player in the drug manufacturing industry with a market capitalization of $10.18 billion. Despite this potential and a low forward P/E ratio, the company faces challenges including a …

Wheaton Precious Metals (TSX:WPM) Stock Still Looks Rich After Q2 Earnings Preview

Wheaton Precious Metals (TSE:WPM) Price Target Raised to C$210.00 at National Bank Financial

Wheaton Precious Metals Corp (WPM) records 23.1% weekly climb as turnover expands

The gold-sector name drew stronger participation, but inactive trend confirmation and negative pressure kept the setup mixed.

AI Trading Plans Come Before Code in Waton’s AlphaSchema

Waton Financial announced research progress on AlphaSchema, a framework for structured, large-language-model-assisted discovery of quantitative trading signals. The company emphasizes prioritizing explicit, inspectable trading hypotheses before code generation, using semantic plans and historical Chinese equity data for backtesting. Waton clarifies that this is a …

What Atmos Energy (ATO)'s Earnings Beat, Guidance Reaffirmation and Leadership Moves Mean For Shareholders

Top Canadian Gold Stocks in August 2026: Agnico Eagle, Wheaton Precious Metals, Franco-Nevada and Kinross Lead the Pack

Dr. Reddy’s (RDY) to end Novartis India brand deal after Sept. 2026

Dr. Reddy's Laboratories Limited announced the termination of its distribution and promotion agreement with Novartis India Limited, effective September 30, 2026. This decision follows a change in the controlling shareholding of Novartis India. Dr. Reddy's will continue to commercialize the covered brands until the …

Mesa Labs Announces First Quarter Results

Mesa Laboratories, Inc. announced its first fiscal quarter results, showing a 1.0% increase in revenues and a 129% increase in operating income. The company reported positive core organic growth driven by its Calibration Solutions and Biopharmaceutical Development divisions, with a significant reduction in its …

Valiant Laboratories: मोठी घोषणा! ₹60 कोटींची गुंतवणूक आणि ऑफिस स्थलांतर

Valiant Laboratories Q1 FY27: सब्सिडियरी के दम पर मुनाफे में भारी उछाल, ₹21.10 करोड़ का नेट प्रॉफिट!

Valiant Laboratories: முதல் காலாண்டில் **₹21.10 கோடி** லாபம், புதிய உச்சத்தை தொட்டது!

Waton Financial Highlights AlphaSchema Research Progress in Structured AI-Assisted Trading Signal Discovery

Waton Financial Limited has announced significant progress with AlphaSchema, a research framework designed for AI-assisted discovery of quantitative trading signals. This initiative, detailed in an arXiv preprint and a public source-code repository, emphasizes transforming model-generated ideas into explicit, testable hypotheses before implementation. The research …

Infleqtion Selected by Eaton to Explore Quantum Computing for Power Grid Resilience

Infleqtion has been chosen by Eaton to provide quantum computing technology for a research program funded by the Air Force Research Laboratory. This collaboration aims to enhance the resilience of the U.S. electrical grid by evaluating how quantum algorithms and neutral-atom quantum hardware can …

Abbott Continues to Oppose Spinal Cord Stimulator Lawsuit MDL, Despite Mounting Claims

Abbott Laboratories is opposing the consolidation of spinal cord stimulator lawsuits into a multidistrict litigation (MDL), despite a growing number of claims alleging dangerous defects in its devices. While a similar MDL has already been established for Boston Scientific, Abbott argues that its cases …

Don't Overlook Bio-Rad (BIO) International Revenue Trends While Assessing the Stock

Have you assessed how the international operations of Bio-Rad Laboratories (BIO) performed in the quarter ended June 2026? For this maker of instruments used in biomedical research, possessing an expansive global footprint, parsing the trends of international revenues could be critical to gauge its …

Atossa Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary

Atossa Therapeutics Inc has reported its earnings summary for the quarter that ended on June 30. The article, sourced from Reuters, provides a brief overview of the company's financial results. Access to the full report is available through a subscription to TradingView.

How Investors Are Reacting To Stevanato Group (STVN) Trimmed Guidance And New GLP-1 Pen Approvals

Stevanato Group S.p.A. recently reported past second-quarter 2026 results showing sales of €302 million with lower net income, slightly trimmed its full-year revenue guidance to €1.26–€1.28 billion, and outlined expected diluted EPS of €0.53–€0.55. At the same time, the company's Alina pen injector platform …

KTOS Looks 89.4% Overvalued on GF Value™

Kratos Defense & Security Solutions Inc (NASDAQ: KTOS) appears significantly overvalued according to GuruFocus's GF Value™ metric, trading 89.4% above its intrinsic value estimate. Despite its role in advancing missile defense technologies and strong growth profile, the company remains unprofitable and cash-flow negative, leading …

Charles River Laboratories , Inc. Stock 12‑Month Price Target Raised to $291.46, Implies 9% Upside

Analysts have raised the 12-month average price target for Charles River Laboratories International, Inc. (CRL) stock from $285.54 to $291.46, implying a 9% potential upside based on its August 7th closing price. The consensus rating from 19 analysts remains "Buy," with a majority recommending …

Infleqtion Selected by Eaton to Support Research Advancing Quantum Computing for U.S. Grid Resilience

Multi-year, multi-million-dollar program focused on leveraging quantum computing to enhance resilience of U.S. electrical grid and reduce economic impact of power outages. LOUISVILLE, Colo., August 10, 2026--(BUSINESS WIRE)--Infleqtion, a global leader in quantum computing and quantum sensing powered by neutral-atom technology, announced that Eaton, …

TD Cowen Adjusts PT on Charles River Laboratories International to $300 From $235, Maintains Buy Rating

TD Cowen has increased its price target for Charles River Laboratories International (CRL) to $300 from $235, while reiterating a Buy rating on the stock. This adjustment comes amidst other analyst updates for the company, indicating positive sentiment following recent financial announcements. The article …

Atmos Energy Names Natural Gas Industry Adviser James Jeffries to Board

Atmos Energy (NYSE: ATO) has appointed James H. Jeffries IV to its board of directors, effective September 1, 2026. Jeffries brings over 30 years of experience advising natural gas utilities and was previously a partner at McGuireWoods LLP. His appointment is expected to strengthen …

Atmos Energy Names Jeff Martinez to Lead Utility Operations as John McDill Retires

Atmos Energy has appointed Jeff D. Martinez as senior vice president of utility operations, effective October 1, 2026, succeeding John S. McDill who plans to retire in early 2027. Martinez, a long-time company executive, will join the Management Committee and report to President and …